Tag: price

VICTORIA, Seychelles, June 05, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, is shaping its long-term strategy, based on its mission – making crypto more accessible to everyone and building trust within the community. Being a significant player in the market, MEXC drives the whole industry. The effect of its recent investments on the crypto space globally is hard to overestimate.

FORM 8.5 (EPT/RI)

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 21 May 2025 regarding the subscription period (the "Subscription Period") in the subsequent offering (the "Subsequent Offering") consisting of up to 600 million new shares at a subscription price of NOK 0.01 per share (“Offer Shares”).

AB “Ignitis grupė” (hereinafter – the Group) informs that Kelmė wind farm II, controlled by its subsidiary UAB “Ignitis renewables” (hereinafter – Ignitis Renewables), has reached the commercial operation date (hereinafter – COD). 

NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A common stock (or common stock equivalents), and warrants to purchase up to 2,768,600 shares of common stock, at a combined public offering price of $3.27 per share and accompanying warrants.

NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cerevel Therapeutics Holdings, Inc. (CERE) on behalf of long-term stockholders following a class action complaint that was filed against Cerevel on April 3, 2025 with a Class Period from October 11, 2023 through August 1, 2024. Our investigation concerns whether the board of directors of Cerevel have breached their fiduciary duties to the company.

NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) on behalf of Tempus stockholders. Our investigation concerns whether Tempus has violated the federal securities laws and/or engaged in other unlawful business practices.